The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Momentum is really gathering this time, October is a great month “In the entire circle of the year there are no days so delightful as those of a fine October.” – Alexander Smith , lets hope so !
Hi San Diego, I think it has from the RNS..see the last sentence, unless I misunderstand your post.
"Richard Marsden, CEO Synairgen, said: "COPD exacerbations are the second most common cause of unplanned hospitalisation in England, behind cardiovascular disease. These interim data from our first trial of SNG001 in COPD show that SNG001 could be a valuable novel therapeutic for exacerbating COPD patients. Overall, SNG001 has now been shown to raise the body's natural viral defences when challenged by a wide variety of respiratory viruses, indicating that it could be an important treatment in the coming virus season, where there may be coinfection with influenza and other viruses alongside COVID-19."
Flu is on the way, Flu vaccine, according to Webmd on 2/92020,only 10% to 60% effective(best year) on average (best) ) effective, likelihood of co-infection with Covid-19, we need treatment SNG001 stored now. France have woken up to it.
Hi Folks its a link to the original trials I think , not an new US one, unless I miss something, but it does show its on the radar screens...
https://racetoacure.stanford.edu/clinical-trials/803
Is this for real ???? looks on the surface very encouraging.
Sorry if this has been posted already, but could not see it
Hi MP sent this WE with note to Sunday Times Business section, I will let you know the outcome.
Enjoy the rest of the WE, (Only 2hrs 27 mins to my allowable beer time on a Sunday, Timothy Taylors Landlord being placed in the fridge)
These Docs are dated early spring Mar /April, when the SNG001 stock was being used for the dble blind trial, the results up in 20/July , At that time the RECOVERY set up/ trial is underway with the other products and joining later would need ethics etc reaaproval. There was maybe a choice reapply now with product or select a new route.
IMHO the with all the good noise re Clinigen, Rentschler and Vectura, there is high confidence that production is well underway, home trials are happening, registrations are ongoing and the greater EU patient population could provide the greater stat numbers required to provide further hard evidence. I think it may have been timing/timelines
I got a 4k tax rebate today, I wonder how many sng shares I will be able to buy next week? Hopefully more than 1 :)
Brysoa great post and post !
I value your and everyones thoughts..
Is it possible to Post on The DT',
Your's and all comments are welcome if it should fly, die or amended.
"Recent news implies that EU patients may get SNG001 first and UK patients could tragically lose out on. Winter is coming and a frightening scenario of potential co-infections of flu and Covid are being predicted, if this happens it will put even greater pressure on our much loved friends and family and NHS and its Critical Care System"
For the beancounters Investors in NUMIS, Note Blackrock IM UK, were in but not as much now.
From AIM 26 page on their site.
"Shares not in public hands: The total number of Numis ordinary shares of 5p each not held in public hands is 29,568,293 (24.97%).
Significant Share Holdings:
IPGL Limited – is deemed interested in 6,420,318 (6.025%) ordinary shares in Numis.
Aviva plc – is deemed interested in 6,743,378 (5.93%) ordinary shares in Numis.
Kayne Anderson Rudnick Investment Management, LLC – is deemed interested in 5,361,456 (5.09%) ordinary shares in Numis.
Unicorn UK Income Fund - is deemed interested in 5,241,000 (4.89%) ordinary shares in Numis.
Nortrust Nominees Limited – is deemed interested in 4,606,424 (4.38%) ordinary shares in Numis.
Cambridge Global Asset Management - is deemed interested in 4,156,966 (3.89%) Ordinary Shares in Numis.
Aktieselskabet af 1.3.2017 – is deemed interested in 24,175,059 (23.0%) ordinary shares in Numis.
Marcus J Chorley – is deemed interested in 3,722,245 (3.46%) ordinary shares in Numis.
BlackRock Investment Management (UK) Limited – interest has fallen below 5% of qualifying instruments in Numis.
Leaf its whats inside the house that counts
pmjh I really value yours and other posters here and tried to grab your attention with a critical care bed post a day or so ago, but to prevent me chat stalking:) if there is such a thing, I revamped it, I am very new to this AIM market chat stuff, but learning how its burns everyday.
I am now 80 minutes past my allowable beer drinking time... So its a glass of malt to catch up I wish you all well.
The PHE article et al are supported in the last set of Sage minutes, Sage 57 to Sage 59, Google "Sage 59 Minutes" and the links all come up, There are some very interesting reports that are published here and the investigations supporting them. These folks are working at break neck speed and are top Scientists. Treatments will be needed IMHO.
I have been asked to go fora jab, googled the rate, 45% effective??? thats 55% not effective on what I found, more treatments will be need if both Viruses take hold, the pressures on critical care beds could huge and SNG100 has demonstrated reduction of these. I think this is one reason France have moved quickly they are in the same Flu/Covid boat as all of us eg the Globe, SNG100 could be the global life saver.
In their own Department publication..
PHE published Document 22 /9/2020 is a key reminder of the huge risks faced.
"Three of the nation’s senior medics – Dr Yvonne Doyle, Professor Jonathan Van-Tam and Dr Nikita Kanani – are calling on all eligible people to get vaccinated against flu, as new research from Public Health England (PHE) suggests the risk of death more than doubled for people who tested positive for both flu and COVID-19, compared to those with COVID-19 alone.
The research, looking at cases between January and April this year, also found that those with co-infection of the 2 viruses were more at risk of severe illness. Most cases of co-infection were in older people and more than half of them died."
Flu is a serious condition that kills, on average, 11,000 people in England each year and hospitalises many more. Adults at high risk from flu are also most at risk from COVID-19. The free vaccine is more important than ever to help protect the nation from a double threat this winter.
https://www.gov.uk/government/news/record-numbers-offered-flu-vaccine-as-those-with-flu-and-covid-19-more-likely-to-die"
`thanks Mat, excellent info, to me the buys and sells are relatively close in volume say set +/- 10% I think,
is it just two main players ?
my worst was Greggs bought high just during early Covid, did not follow my rules, I have 53 shares to remind me...
Maybe they could develop the steak bake as an anti obesity drug delivery system, now where is the patent office number :)
Mine was JnJ , and it hardly moved much, First lesson learn look ahead and see what is coming, made about £20 before costs . I think they went on to bigger things :)
I keep this quote close by me
"Many of life's failures are people who did not realize how close they were to success when they gave up." -Thomas A. Edison
I was thinking how we could help get the word out there, can we send the MAP contact details out via our own networks with a key message and make some noise on this?
Healthcare professionals in the EU can obtain details about the SNG001 Managed Access Programby calling the customer service team at +44 (0) 1283 494 340 or emailing medicineaccess@clinigengroup.com.
Any problem with this ?